Series B - Abbisko Therapeutics - Mar 21, 2019 Funding Round Profile - Cointime

Bitcoin $87,738.69 -0.09%
Ethereum $3,233.41 -2.67%
BNB $614.94 -5.37%
Optimism $1.61 -10.51%
Arbitrum $0.61 -7.35%
Solana $207.06 -4.81%
Polygon $0.39 -7.35%
Cosmos $5.10 -8.50%
Avalanche $32.96 -7.09%

Bitcoin $87,738.69 -0.09%
Ethereum $3,233.41 -2.67%
BNB $614.94 -5.37%
Optimism $1.61 -10.51%
Arbitrum $0.61 -7.35%
Solana $207.06 -4.81%
Polygon $0.39 -7.35%
Cosmos $5.10 -8.50%
Avalanche $32.96 -7.09%

Abbisko Therapeutics

company

Funding Round

Series B

Money Raised

$ 42M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 7, 2017	Series A	$ 28M	Lilly Asia Ventures	Detail